Parameters . | Control Values (15) . | P2 . | P4 . | P7 . | OI Type I (19) . |
---|---|---|---|---|---|
Age at biopsy, y | 11–13.9 | 12 | 12 | 13 | 7.6 ± 3.8 |
Structural parameters | |||||
BV/TV, % | 24.4 ± 4.3 | —a | 17.98 | 4.46 | 11.0 ± 5.2 |
Tb.Th, μm | 148 ± 23 | 93.43 | 141.64 | 53.94 | 105.0 ± 25 |
Tb.N, /mm | 1.66 ± 0.22 | —a | 1.27 | 0.83 | 1.3 ± 0.39 |
Ct.Wi, mm | 0.90 ± 0.33b | 0.81a | 0.60 | 0.56 | 0.52 ± 0.20 |
Static parameters of bone formation | |||||
OV/BV, % | 2.12 ± 1.0 | 4.18 | 1.97 | 4.73 | 5.2 ± 2.6 |
O.Th, µm | 6.7 ± 1.7 | 4.55 | 7.94 | 3.43 | 5.5 ± 1.7 |
OS/BS, % | 22.1 ± 7.8 | 54.22 | 17.23 | 38.08 | 48 ± 14 |
Ob.S/BS, % | 6.7 ± 4.5 | 2.97 | 0.96 | 8.98 | 19.4 ± 9.5 |
Dynamic parameters of bone formation | |||||
MS/BS, % | 11.07 ± 5.0 | 7.05 | N/A | 9.93 | 48 ± 16 |
MAR, µm/d | 0.87 ± 0.09 | 0.92 | N/A | 0.77 | 0.73 ± 0.18 |
Aj.AR, µm/d | 0.46 ± 0.10 | 0.12 | N/A | 0.20 | 0.35 ± 0.14 |
BFR/BS, µm/y | 37.3 ± 16.7 | 23.77 | N/A | 27.75 | 77 ± 34 |
BFR/BV, %/y | 49.9 ± 21.4 | 50.28 | N/A | 108.18 | 116 ± 62 |
Mlt, d | 14.5 ± 3.00 | 37.88 | N/A | 17.18 | 16.5 (12.5–19.8) |
Static parameters of bone resorption | |||||
ES/BS, % | 14.9 ± 5.6 | 2.94 | 1.55 | 0 | 15.6 (13.7–21.8) |
Oc.S/BS, % | 1.14 ± 0.74 | 0.15 | 0.10 | 0 | 1.37 (1.05–1.70) |
N.Oc/BS, /mm | 0.29 ± 0.14 | 0.04 | 0.03 | 0 | 0.47 ± 0.29 |
Parameters . | Control Values (15) . | P2 . | P4 . | P7 . | OI Type I (19) . |
---|---|---|---|---|---|
Age at biopsy, y | 11–13.9 | 12 | 12 | 13 | 7.6 ± 3.8 |
Structural parameters | |||||
BV/TV, % | 24.4 ± 4.3 | —a | 17.98 | 4.46 | 11.0 ± 5.2 |
Tb.Th, μm | 148 ± 23 | 93.43 | 141.64 | 53.94 | 105.0 ± 25 |
Tb.N, /mm | 1.66 ± 0.22 | —a | 1.27 | 0.83 | 1.3 ± 0.39 |
Ct.Wi, mm | 0.90 ± 0.33b | 0.81a | 0.60 | 0.56 | 0.52 ± 0.20 |
Static parameters of bone formation | |||||
OV/BV, % | 2.12 ± 1.0 | 4.18 | 1.97 | 4.73 | 5.2 ± 2.6 |
O.Th, µm | 6.7 ± 1.7 | 4.55 | 7.94 | 3.43 | 5.5 ± 1.7 |
OS/BS, % | 22.1 ± 7.8 | 54.22 | 17.23 | 38.08 | 48 ± 14 |
Ob.S/BS, % | 6.7 ± 4.5 | 2.97 | 0.96 | 8.98 | 19.4 ± 9.5 |
Dynamic parameters of bone formation | |||||
MS/BS, % | 11.07 ± 5.0 | 7.05 | N/A | 9.93 | 48 ± 16 |
MAR, µm/d | 0.87 ± 0.09 | 0.92 | N/A | 0.77 | 0.73 ± 0.18 |
Aj.AR, µm/d | 0.46 ± 0.10 | 0.12 | N/A | 0.20 | 0.35 ± 0.14 |
BFR/BS, µm/y | 37.3 ± 16.7 | 23.77 | N/A | 27.75 | 77 ± 34 |
BFR/BV, %/y | 49.9 ± 21.4 | 50.28 | N/A | 108.18 | 116 ± 62 |
Mlt, d | 14.5 ± 3.00 | 37.88 | N/A | 17.18 | 16.5 (12.5–19.8) |
Static parameters of bone resorption | |||||
ES/BS, % | 14.9 ± 5.6 | 2.94 | 1.55 | 0 | 15.6 (13.7–21.8) |
Oc.S/BS, % | 1.14 ± 0.74 | 0.15 | 0.10 | 0 | 1.37 (1.05–1.70) |
N.Oc/BS, /mm | 0.29 ± 0.14 | 0.04 | 0.03 | 0 | 0.47 ± 0.29 |
For comparison, typical values for patients with OI type I are given (19). P4 did not receive tetracycline labeling.
Abbreviations: Aj.AR, adjusted apposition rate; BFR, bone formation rate; Ct.Wi, cortical thickness (width); MAR, mineral apposition rate; Mlt, mineralization lag time; MS, mineralizing surface; N/A, not applicable; N.Oc, osteoclast number; Ob.S, OB surface; Oc.S, osteoclast surface; OS, osteoid surface; O.Th, osteoid thickness; OV, osteoid volume; Tb.N, trabecular number; Tb.Th, trabecular thickness.
Sample contained only one cortical plate. Therefore, BV/TV and Tb.N could not be assessed.
Mean value from two cortical plates.
Parameters . | Control Values (15) . | P2 . | P4 . | P7 . | OI Type I (19) . |
---|---|---|---|---|---|
Age at biopsy, y | 11–13.9 | 12 | 12 | 13 | 7.6 ± 3.8 |
Structural parameters | |||||
BV/TV, % | 24.4 ± 4.3 | —a | 17.98 | 4.46 | 11.0 ± 5.2 |
Tb.Th, μm | 148 ± 23 | 93.43 | 141.64 | 53.94 | 105.0 ± 25 |
Tb.N, /mm | 1.66 ± 0.22 | —a | 1.27 | 0.83 | 1.3 ± 0.39 |
Ct.Wi, mm | 0.90 ± 0.33b | 0.81a | 0.60 | 0.56 | 0.52 ± 0.20 |
Static parameters of bone formation | |||||
OV/BV, % | 2.12 ± 1.0 | 4.18 | 1.97 | 4.73 | 5.2 ± 2.6 |
O.Th, µm | 6.7 ± 1.7 | 4.55 | 7.94 | 3.43 | 5.5 ± 1.7 |
OS/BS, % | 22.1 ± 7.8 | 54.22 | 17.23 | 38.08 | 48 ± 14 |
Ob.S/BS, % | 6.7 ± 4.5 | 2.97 | 0.96 | 8.98 | 19.4 ± 9.5 |
Dynamic parameters of bone formation | |||||
MS/BS, % | 11.07 ± 5.0 | 7.05 | N/A | 9.93 | 48 ± 16 |
MAR, µm/d | 0.87 ± 0.09 | 0.92 | N/A | 0.77 | 0.73 ± 0.18 |
Aj.AR, µm/d | 0.46 ± 0.10 | 0.12 | N/A | 0.20 | 0.35 ± 0.14 |
BFR/BS, µm/y | 37.3 ± 16.7 | 23.77 | N/A | 27.75 | 77 ± 34 |
BFR/BV, %/y | 49.9 ± 21.4 | 50.28 | N/A | 108.18 | 116 ± 62 |
Mlt, d | 14.5 ± 3.00 | 37.88 | N/A | 17.18 | 16.5 (12.5–19.8) |
Static parameters of bone resorption | |||||
ES/BS, % | 14.9 ± 5.6 | 2.94 | 1.55 | 0 | 15.6 (13.7–21.8) |
Oc.S/BS, % | 1.14 ± 0.74 | 0.15 | 0.10 | 0 | 1.37 (1.05–1.70) |
N.Oc/BS, /mm | 0.29 ± 0.14 | 0.04 | 0.03 | 0 | 0.47 ± 0.29 |
Parameters . | Control Values (15) . | P2 . | P4 . | P7 . | OI Type I (19) . |
---|---|---|---|---|---|
Age at biopsy, y | 11–13.9 | 12 | 12 | 13 | 7.6 ± 3.8 |
Structural parameters | |||||
BV/TV, % | 24.4 ± 4.3 | —a | 17.98 | 4.46 | 11.0 ± 5.2 |
Tb.Th, μm | 148 ± 23 | 93.43 | 141.64 | 53.94 | 105.0 ± 25 |
Tb.N, /mm | 1.66 ± 0.22 | —a | 1.27 | 0.83 | 1.3 ± 0.39 |
Ct.Wi, mm | 0.90 ± 0.33b | 0.81a | 0.60 | 0.56 | 0.52 ± 0.20 |
Static parameters of bone formation | |||||
OV/BV, % | 2.12 ± 1.0 | 4.18 | 1.97 | 4.73 | 5.2 ± 2.6 |
O.Th, µm | 6.7 ± 1.7 | 4.55 | 7.94 | 3.43 | 5.5 ± 1.7 |
OS/BS, % | 22.1 ± 7.8 | 54.22 | 17.23 | 38.08 | 48 ± 14 |
Ob.S/BS, % | 6.7 ± 4.5 | 2.97 | 0.96 | 8.98 | 19.4 ± 9.5 |
Dynamic parameters of bone formation | |||||
MS/BS, % | 11.07 ± 5.0 | 7.05 | N/A | 9.93 | 48 ± 16 |
MAR, µm/d | 0.87 ± 0.09 | 0.92 | N/A | 0.77 | 0.73 ± 0.18 |
Aj.AR, µm/d | 0.46 ± 0.10 | 0.12 | N/A | 0.20 | 0.35 ± 0.14 |
BFR/BS, µm/y | 37.3 ± 16.7 | 23.77 | N/A | 27.75 | 77 ± 34 |
BFR/BV, %/y | 49.9 ± 21.4 | 50.28 | N/A | 108.18 | 116 ± 62 |
Mlt, d | 14.5 ± 3.00 | 37.88 | N/A | 17.18 | 16.5 (12.5–19.8) |
Static parameters of bone resorption | |||||
ES/BS, % | 14.9 ± 5.6 | 2.94 | 1.55 | 0 | 15.6 (13.7–21.8) |
Oc.S/BS, % | 1.14 ± 0.74 | 0.15 | 0.10 | 0 | 1.37 (1.05–1.70) |
N.Oc/BS, /mm | 0.29 ± 0.14 | 0.04 | 0.03 | 0 | 0.47 ± 0.29 |
For comparison, typical values for patients with OI type I are given (19). P4 did not receive tetracycline labeling.
Abbreviations: Aj.AR, adjusted apposition rate; BFR, bone formation rate; Ct.Wi, cortical thickness (width); MAR, mineral apposition rate; Mlt, mineralization lag time; MS, mineralizing surface; N/A, not applicable; N.Oc, osteoclast number; Ob.S, OB surface; Oc.S, osteoclast surface; OS, osteoid surface; O.Th, osteoid thickness; OV, osteoid volume; Tb.N, trabecular number; Tb.Th, trabecular thickness.
Sample contained only one cortical plate. Therefore, BV/TV and Tb.N could not be assessed.
Mean value from two cortical plates.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.